Table 1.
Characteristics of the Study Population According to the Type of Leukemia.
| Non-APL | APL | P-value | |
|---|---|---|---|
| Age (years), range | 48.59(18–83) | 42.9 (14–84) | <0.001 |
| Gender | 0.21 | ||
| Male, No. (%) | 95(47.3) | 212(52.7) | |
| Female, No. (%) | 106(52.7) | 190(47.3) | |
| Height (cm), range | 164.59(146–185) | 164.62(148–184) | 0.968 |
| Weight (kg), range | 61.38(35.5–100) | 62.16(38–101) | 0.461 |
| BMI(kg/m2), range | 22.59(0.5–98.8) | 22.83(0.2–117.2) | 0.426 |
| Underweight/normal, | 168(83.6) | 250(77.9) | 0.1 |
| BMI<25, No. (%) | |||
| Overweight/obese, | 33(16.4) | 71(22.1) | |
| BMI≥25, No. (%) | |||
| WBC(10 ×109/L), range | 35.55(0.5–98.8) | 12.70(0.2–117.2) | <0.001 |
| ≥10 ×109/L, No. (%) 97(48.3) | 118(29.5) | <0.001 | |
| <10 ×109/L, No. (%) 104(51.7) | 282(70.5) | ||
| HBG*(g/L), range PLT*(10 ×109/L), range |
90.96(48–161) 62.31(6–361) |
88.59(41–157) 36.65(4–225) |
0.325 <0.001 |
| ALB*(g/L), range | 40.47(28.5–53.4) | 42.48(25.3–66.8) | 0.095 |
| ALT*(U/L), range | 27.99(5–389) | 32.68(4–560) | 0.068 |
| AST*(U/L), range | 27.17(7–539) | 31.49(6–367) | 0.062 |
| Cr*(μmol/L), range | 63.74(32–170) | 64.96(18–322) | 0.315 |
| UA*(μmol/L), range | 270.21(96–578) | 235.44(36–561) | 0.288 |
| LDH*(IU/L), range | 708.38(129–1025) | 465.49(115–4462) | <0.001 |
| TG*(mmol/L), range | 1.57(0.44–10.39) | 2.29(0.43–20.86) | <0.001 |
| HTG group | 57(28.4) | 211(55.8) | <0.001 |
| TG≥1.70, No. (%) | |||
| TC*(mmol/L), range | 3.45±1.09(0.96–7.13) | 4.28(1.96–7.68) | <0.001 |
| HDL*(mmol/L), range | 0.86(0.23–2.44) | 0.97(0.15−4.27) | 0.002 |
| LDL*(mmol/L), range | 1.84(0.11−3.67) | 2.28(0.11–4.99) | <0.001 |
| Glucose*(mmol/L), range | 5.67(2.14–14.51) | 6.65(3.35–33.71) | <0.001 |
APL, acute promyelocytic leukemia; non-APL, acute myeloid leukemia exclude of APL; BMI, body mass index; WBC, white blood cell; HBG, Hemoglobin count; PLT, platelet count; ALB, albumin; ALT, alanine transaminase; AST, aspartate transaminase; Cr, serum creatinine; UA, uric acid; LDH, lactate dehydrogenas; TG, triglyceride; HTG group, high triglyceride group ≥ 1.70 (mmol/L); TC, cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.